# Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.

> **NCT01398306** · — · COMPLETED · sponsor: **University Medical Center Groningen** · enrollment: 40 (actual)

## Conditions studied

- Carcinoma
- Carcinoma, Renal Cell
- Neuroendocrine Tumors
- Carcinoid Tumor
- Pancreatic Islet Cell Tumors

## Interventions

- **OTHER:** Blood sampling by vena punction.

## Key facts

- **NCT ID:** NCT01398306
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01398306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01398306, "Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01398306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
